Intervention Review

You have free access to this content

Mitoxantrone for multiple sclerosis

  1. Filippo Martinelli Boneschi1,*,
  2. Laura Vacchi2,
  3. Marco Rovaris3,
  4. Ruggero Capra4,
  5. Giancarlo Comi5

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 30 MAY 2013

DOI: 10.1002/14651858.CD002127.pub3

How to Cite

Martinelli Boneschi F, Vacchi L, Rovaris M, Capra R, Comi G. Mitoxantrone for multiple sclerosis. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD002127. DOI: 10.1002/14651858.CD002127.pub3.

Author Information

  1. 1

    INSPE - San Raffaele Scientific Institute, Department of Neurology, Milano, Italy

  2. 2

    Scientific Institute and University Ospedale San Raffaele, Institute of Experimental Neurology (INSPE), Milano, Italy

  3. 3

    I.R.C.S.S. S. Maria Nascente - Fondazione Don Gnocchi, U.O. Sclerosi Multipla, Milano, Italy

  4. 4

    Spedali Civili, Brescia, Italy

  5. 5

    San Raffaele Hospital, Department of Neurology, Milano, Italy

*Filippo Martinelli Boneschi, Department of Neurology, INSPE - San Raffaele Scientific Institute, Via Olgettina, 48, Milano, 20131, Italy.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 31 MAY 2013


Cited in:


This article has been cited by:

  1. 1
    N. Melzer, S. G. Meuth, Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies, Clinical & Experimental Immunology, 2014, 175, 3
  2. 2
    Filippo Martinelli Boneschi, Laura Vacchi, Marco Rovaris, Ruggero Capra, Giancarlo Comi, Mitoxantrone for multiple sclerosis, The Cochrane Library,